Effect of combined mirabegron and desmopressin (DDAVP) on neurogenic detrusor overactivity (NDO) in patient with multiple sclerosis.
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Desmopressin (Primary) ; Mirabegron (Primary) ; Solifenacin
- Indications Bladder disorders
- Focus Therapeutic Use
- 14 Feb 2018 New trial record